Ligand profile
ZINC100004560
Virtual-screening candidate from ZINC.
Bound to: KP13_03859 — Dihydroorotate dehydrogenase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC100004560- UniProt (similar protein)
Q02127- Tanimoto
- 1.000
- Target protein
- KP13_03859
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 52.8
- −1 ≤ LogP ≤ 5 4.00
- MW ≤ 500 Da 263.3
- LogP ≤ 5 4.00
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 52.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Oc1ccc(/C=N/c2cccc3ccccc23)c(O)c1Oc1ccc(/C=N/c2cccc3ccccc23)c(O)c1
InChI=1S/C17H13NO2/c19-14-9-8-13(17(20)10-14)11-18-16-7-3-5-12-4-1-2-6-15(12)16/h1-11,19-20H/b18-11+InChI=1S/C17H13NO2/c19-14-9-8-13(17(20)10-14)11-18-16-7-3-5-12-4-1-2-6-15(12)16/h1-11,19-20H/b18-11+
RJBRMIUDYFYKSS-WOJGMQOQSA-NRJBRMIUDYFYKSS-WOJGMQOQSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- CHEMBL2178107
- Homolog
- Q02127
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC100004560 →
- ZINC ZINC20 ZINC100004560 →
- UniProt UniProt Q02127 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC100004560”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03859.
PDB 75
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).